|Title:||Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015||Authors:||Weng, Meng-Tzu
|Keywords:||5-aminosalicylic acid; anti-tumor necrosis factor-α agents; corticosteroids; inflammatory bowel disease; thiopurine;5-aminosalicylic acid; Anti-tumor necrosis factor-α agents; Corticosteroids; Inflammatory bowel disease; Thiopurine||Issue Date:||27-Oct-2018||Journal Volume:||7||Journal Issue:||11||Source:||Journal of clinical medicine||Abstract:||
No nationwide, long-term follow-up study has assessed medication-associated outcomes for Asian patients with inflammatory bowel disease (IBD). This study examined medication-associated outcomes for Taiwanese patients with IBD.
|URI:||https://scholars.lib.ntu.edu.tw/handle/123456789/587257||ISSN:||2077-0383||DOI:||10.3390/jcm7110394||metadata.dc.subject.other:||aminosalicylic acid; corticosteroid; entecavir; ethambutol; isoniazid; lamivudine; mercaptopurine; pyrazinamide; rifampicin; tenofovir; tumor necrosis factor inhibitor; abdominal abscess; adult; Article; cohort analysis; colon resection; colorectal cancer; controlled study; drug use; environmental factor; evaluation and follow up; female; genetic susceptibility; hazard ratio; hepatitis B; hospitalization; human; hyperlipidemia; hypertension; ICD-9-CM; ileostomy; incidence; inflammatory bowel disease; laparotomy; liver cancer; long term care; major clinical study; male; medication compliance; middle aged; outcome assessment; pneumonia; recommended drug dose; retrospective study; risk factor; sepsis; Taiwanese; terminal disease; tuberculosis; urinary tract infection
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.